VST BIO Announces Groundbreaking Data from Non-Human Primate Study Evaluating Novel Monoclonal Antibody to Treat Ischemic Stroke at AHA International Stroke Conference

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

VST-Bio-Corp-study-UK

More Like This

Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury

PR Newswire associated0

Simcere Phar-maceuticals Presented Six Studies on Sanbexin® at ESOC 2024

PR Newswire associated0

A major advance on stroke at Montpellier University Hospital published in the New England Journal of Medicine

PR Newswire associated0

Medtech Startup AI-Stroke Raises $4.6 Million to Bring Artificial Intelligence to Pre-CT Emergency Stroke Care

XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke

PR Newswire associated0

S&E bio Receives Korea's First Approval for Exosome-Based Therapy Clinical Trial

PR Newswire associated0

Brainomix Announces New Studies Further Validating the Impact of Brainomix 360 Stroke Platform

Exidavnemab phase 2a study expanded to include MSA patients